Senior Director, Global Market Access Oncology Early Assets/Business Development
Bristol Myers Squibb
19 days ago
Remote friendly (Princeton, NJ)
United States
Market Access
Summary:
The Senior Director, Global Market Access – Early Assets & Business Development will provide value, access, and pricing considerations into BMS governance to maximize portfolio value and lifecycle management.
Responsibilities:
- Serve as functional leader/mentor for Global Market Access – EA & BD and lead Directors in Oncology therapeutic area.
- Develop comprehensive early market access strategies; provide strategic access input into governance (where to play/how to win) amid evolving pricing reforms.
- Inform future access strategy for new compounds: assess clinical development strategies; define evidence generation and mitigation plans for market access/pricing opportunities and challenges.
- Support Early Assets & BD requests from early commercialization, clinical development, and BD leadership; collaborate with market access strategy leads prior to ID4.
- Use BD DEAL frameworks and Early Asset Review (EAR) for due diligence and early asset/portfolio considerations.
- Monitor external environment and synthesize inputs into protocol design (endpoints, comparator, dosing, population/subpopulation) and mitigation activities with Pricing, HEOR, Medical & Local Markets.
- Partner cross-functionally to position products for success in an evolving access landscape; ensure activities comply with regulations and corporate/legal policies.
Qualifications:
- Undergraduate degree required; MBA and/or post-graduate degree preferred.
- 8+ years Market Access/Commercial experience with track record in market access strategy, pricing and/or HEOR (WW and/or US); leadership experience preferred.
- Strong understanding of global Market Access environment; specialized Market Access/Pricing/Reimbursement expertise; HTA systems/data requirements.
- Deep knowledge of drug development/commercialization, HTA assessment, reimbursement, and payer perspectives.
- Scientific background (preferably oncology/hematology) to link trial design to payer strategy and identify relevant endpoints/outcomes research.
- Ability to create market access scenarios, lead cross-functional teams, and translate clinical value to economic value.
Benefits/Compensation (as stated): $210,600–$255,203 (Princeton, NJ, US); additional incentive cash/stock may be available.
Application instruction:
“If you come across a role that intrigues you but doesn’t perfectly line up… we encourage you to apply anyway.”
The Senior Director, Global Market Access – Early Assets & Business Development will provide value, access, and pricing considerations into BMS governance to maximize portfolio value and lifecycle management.
Responsibilities:
- Serve as functional leader/mentor for Global Market Access – EA & BD and lead Directors in Oncology therapeutic area.
- Develop comprehensive early market access strategies; provide strategic access input into governance (where to play/how to win) amid evolving pricing reforms.
- Inform future access strategy for new compounds: assess clinical development strategies; define evidence generation and mitigation plans for market access/pricing opportunities and challenges.
- Support Early Assets & BD requests from early commercialization, clinical development, and BD leadership; collaborate with market access strategy leads prior to ID4.
- Use BD DEAL frameworks and Early Asset Review (EAR) for due diligence and early asset/portfolio considerations.
- Monitor external environment and synthesize inputs into protocol design (endpoints, comparator, dosing, population/subpopulation) and mitigation activities with Pricing, HEOR, Medical & Local Markets.
- Partner cross-functionally to position products for success in an evolving access landscape; ensure activities comply with regulations and corporate/legal policies.
Qualifications:
- Undergraduate degree required; MBA and/or post-graduate degree preferred.
- 8+ years Market Access/Commercial experience with track record in market access strategy, pricing and/or HEOR (WW and/or US); leadership experience preferred.
- Strong understanding of global Market Access environment; specialized Market Access/Pricing/Reimbursement expertise; HTA systems/data requirements.
- Deep knowledge of drug development/commercialization, HTA assessment, reimbursement, and payer perspectives.
- Scientific background (preferably oncology/hematology) to link trial design to payer strategy and identify relevant endpoints/outcomes research.
- Ability to create market access scenarios, lead cross-functional teams, and translate clinical value to economic value.
Benefits/Compensation (as stated): $210,600–$255,203 (Princeton, NJ, US); additional incentive cash/stock may be available.
Application instruction:
“If you come across a role that intrigues you but doesn’t perfectly line up… we encourage you to apply anyway.”